The clinical relevance of serum CYFRA 21-1 assay in patients with ovarian cancer

This publication has 18 references indexed in Scilit:

• CYFRA 21‐1 is a useful marker for esophageal squamous cell carcinoma
  Cancer, 1997
• Evaluation of TATI and CYFRA 21-1 in Patients with Head and Neck Squamous Cell Carcinoma
  ORL, 1997
• Clinical value of pretreatment serum Cyfra 21–1, tissue polypeptide antigen, and squamous cell carcinoma antigen levels in patients with cervical cancer
  Cancer, 1995
• Cytokeratin Subunit 19 Measured by CYFRA 21-1 Assay in Follow-up of Cervical Cancer
  Gynecologic Oncology, 1995
• Cytokeratin Fragment 21-1 in Gynecologic Malignancy: Comparison with Cancer Antigen 125 and Squamous Cell Carcinoma-Related Antigen
  Tumor Biology, 1995
• Prognostic Significance of Serum Fragments of Cytokeratin 19 Measured by Cyfra 21-1 in Cervical Cancer
  Gynecologic Oncology, 1994
• Evaluation of a new tumour marker in patients with non-small-cell lung cancer: Cyfra 21.1
  British Journal of Cancer, 1994
• CYFRA 21-1, a sensitive and specific new tumour marker for squamous cell lung cancer. Report of the first European multicentre evaluation
  European Journal Of Cancer, 1994
• Patterns of Expression and Organization of Cytokeratin Intermediate Filaments
  Annals of the New York Academy of Sciences, 1985
• The catalog of human cytokeratins: Patterns of expression in normal epithelia, tumors and cultured cells
  Published by Elsevier ,1982